Further analysis indicated that high levels of LBX2-AS1 expression were significantly associated with advanced tumor–node–metastasis (TNM) staging, frequent local invasion, and extensive lymph node metastasis, which are aggressive characteristics of CRC. This evidence concerns the gene LBX2 and neoplasm.